Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D006084:Graft Rejection / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D016027:Heart Transplantation; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D008795:Metronidazole / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D008920:Misonidazole / Q000031:analogs & derivatives / Q000494:pharmacology*; D009593:Nitroimidazoles / Q000494:pharmacology*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D016038:Skin Transplantation
D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D008795:Metronidazole; D008920:Misonidazole; C009997:desmethylmisonidazole